Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?

Young Woo Chang, Hwan Soo Kim, Hoon Yub Kim, Jae Bok Lee, Jeoung Won Bae, Gil Soo Son

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background Central lymph node dissection (CLND) in patients with papillary thyroid microcarcinoma (PTMC) is still controversial. The aim of this study was to examine the risk factors and the incidence of central lymph node metastases (CLNMs) in patients with PTMC who underwent thyroidectomy and CLND. Patients and methods Between 2002 and 2013, 613 patients were enrolled who underwent thyroidectomy with routine CLND for PTMC at the Korea University Medical Center, Ansan Hospital and risk factors and the incidence of CLNM were analyzed. In addition, we also evaluated the complications after thyroidectomy with CLND. Results Out of 613 patients, 239 (39.0%) were found to have CLNM. Male sex (p = 0.012), tumor size ≥ 0.5 cm (p = 0.001), capsular invasion or extrathyroidal extension (p = 0.029), and multifocality (p = 0.004) were independent risk factors for CLNM. Among the 69 patients who had PTMC without these risk factors, CLNM was identified in 12 (17.4%). In this study group, two (0.3%) had permanent recurrent laryngeal nerve injury, two (0.3%) had persistent hypocalcemia, and two (0.3%) developed postoperative hemorrhage. Conclusion CLNM in PTMC is highly prevalent in male sex, tumor size ≥ 0.5 cm, extrathyroidal extension, and multifocality. Even in PTMC patients without these risk factors, the incidence of CLNM is rather higher than expected, and the complication rate of thyroidectomy with CLND is acceptable. Thus, CLND should be considered in all patients with PTMC.

Original languageEnglish
Pages (from-to)197-201
Number of pages5
JournalAsian Journal of Surgery
Volume39
Issue number4
DOIs
Publication statusPublished - 2016 Oct 1

Fingerprint

Lymph Node Excision
Lymph Nodes
Neoplasm Metastasis
Thyroidectomy
Incidence
Recurrent Laryngeal Nerve Injuries
Postoperative Hemorrhage
Hypocalcemia
Papillary Thyroid Microcarcinoma
Korea
Neoplasms

Keywords

  • central lymph node
  • papillary thyroid cancer
  • papillary thyroid microcarcinoma

ASJC Scopus subject areas

  • Surgery

Cite this

Should central lymph node dissection be considered for all papillary thyroid microcarcinoma? / Chang, Young Woo; Kim, Hwan Soo; Kim, Hoon Yub; Lee, Jae Bok; Bae, Jeoung Won; Son, Gil Soo.

In: Asian Journal of Surgery, Vol. 39, No. 4, 01.10.2016, p. 197-201.

Research output: Contribution to journalArticle

@article{c410de5a00bb46098785309f4fe7f014,
title = "Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?",
abstract = "Background Central lymph node dissection (CLND) in patients with papillary thyroid microcarcinoma (PTMC) is still controversial. The aim of this study was to examine the risk factors and the incidence of central lymph node metastases (CLNMs) in patients with PTMC who underwent thyroidectomy and CLND. Patients and methods Between 2002 and 2013, 613 patients were enrolled who underwent thyroidectomy with routine CLND for PTMC at the Korea University Medical Center, Ansan Hospital and risk factors and the incidence of CLNM were analyzed. In addition, we also evaluated the complications after thyroidectomy with CLND. Results Out of 613 patients, 239 (39.0{\%}) were found to have CLNM. Male sex (p = 0.012), tumor size ≥ 0.5 cm (p = 0.001), capsular invasion or extrathyroidal extension (p = 0.029), and multifocality (p = 0.004) were independent risk factors for CLNM. Among the 69 patients who had PTMC without these risk factors, CLNM was identified in 12 (17.4{\%}). In this study group, two (0.3{\%}) had permanent recurrent laryngeal nerve injury, two (0.3{\%}) had persistent hypocalcemia, and two (0.3{\%}) developed postoperative hemorrhage. Conclusion CLNM in PTMC is highly prevalent in male sex, tumor size ≥ 0.5 cm, extrathyroidal extension, and multifocality. Even in PTMC patients without these risk factors, the incidence of CLNM is rather higher than expected, and the complication rate of thyroidectomy with CLND is acceptable. Thus, CLND should be considered in all patients with PTMC.",
keywords = "central lymph node, papillary thyroid cancer, papillary thyroid microcarcinoma",
author = "Chang, {Young Woo} and Kim, {Hwan Soo} and Kim, {Hoon Yub} and Lee, {Jae Bok} and Bae, {Jeoung Won} and Son, {Gil Soo}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.asjsur.2015.02.006",
language = "English",
volume = "39",
pages = "197--201",
journal = "Asian Journal of Surgery",
issn = "1015-9584",
publisher = "Elsevier Taiwan LLC",
number = "4",

}

TY - JOUR

T1 - Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?

AU - Chang, Young Woo

AU - Kim, Hwan Soo

AU - Kim, Hoon Yub

AU - Lee, Jae Bok

AU - Bae, Jeoung Won

AU - Son, Gil Soo

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background Central lymph node dissection (CLND) in patients with papillary thyroid microcarcinoma (PTMC) is still controversial. The aim of this study was to examine the risk factors and the incidence of central lymph node metastases (CLNMs) in patients with PTMC who underwent thyroidectomy and CLND. Patients and methods Between 2002 and 2013, 613 patients were enrolled who underwent thyroidectomy with routine CLND for PTMC at the Korea University Medical Center, Ansan Hospital and risk factors and the incidence of CLNM were analyzed. In addition, we also evaluated the complications after thyroidectomy with CLND. Results Out of 613 patients, 239 (39.0%) were found to have CLNM. Male sex (p = 0.012), tumor size ≥ 0.5 cm (p = 0.001), capsular invasion or extrathyroidal extension (p = 0.029), and multifocality (p = 0.004) were independent risk factors for CLNM. Among the 69 patients who had PTMC without these risk factors, CLNM was identified in 12 (17.4%). In this study group, two (0.3%) had permanent recurrent laryngeal nerve injury, two (0.3%) had persistent hypocalcemia, and two (0.3%) developed postoperative hemorrhage. Conclusion CLNM in PTMC is highly prevalent in male sex, tumor size ≥ 0.5 cm, extrathyroidal extension, and multifocality. Even in PTMC patients without these risk factors, the incidence of CLNM is rather higher than expected, and the complication rate of thyroidectomy with CLND is acceptable. Thus, CLND should be considered in all patients with PTMC.

AB - Background Central lymph node dissection (CLND) in patients with papillary thyroid microcarcinoma (PTMC) is still controversial. The aim of this study was to examine the risk factors and the incidence of central lymph node metastases (CLNMs) in patients with PTMC who underwent thyroidectomy and CLND. Patients and methods Between 2002 and 2013, 613 patients were enrolled who underwent thyroidectomy with routine CLND for PTMC at the Korea University Medical Center, Ansan Hospital and risk factors and the incidence of CLNM were analyzed. In addition, we also evaluated the complications after thyroidectomy with CLND. Results Out of 613 patients, 239 (39.0%) were found to have CLNM. Male sex (p = 0.012), tumor size ≥ 0.5 cm (p = 0.001), capsular invasion or extrathyroidal extension (p = 0.029), and multifocality (p = 0.004) were independent risk factors for CLNM. Among the 69 patients who had PTMC without these risk factors, CLNM was identified in 12 (17.4%). In this study group, two (0.3%) had permanent recurrent laryngeal nerve injury, two (0.3%) had persistent hypocalcemia, and two (0.3%) developed postoperative hemorrhage. Conclusion CLNM in PTMC is highly prevalent in male sex, tumor size ≥ 0.5 cm, extrathyroidal extension, and multifocality. Even in PTMC patients without these risk factors, the incidence of CLNM is rather higher than expected, and the complication rate of thyroidectomy with CLND is acceptable. Thus, CLND should be considered in all patients with PTMC.

KW - central lymph node

KW - papillary thyroid cancer

KW - papillary thyroid microcarcinoma

UR - http://www.scopus.com/inward/record.url?scp=84928041550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928041550&partnerID=8YFLogxK

U2 - 10.1016/j.asjsur.2015.02.006

DO - 10.1016/j.asjsur.2015.02.006

M3 - Article

C2 - 25913730

AN - SCOPUS:84928041550

VL - 39

SP - 197

EP - 201

JO - Asian Journal of Surgery

JF - Asian Journal of Surgery

SN - 1015-9584

IS - 4

ER -